BGI Genomics Co., Ltd. (SHE:300676)
47.66
+0.16 (0.34%)
Oct 23, 2025, 3:04 PM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 18.23 billion as of October 23, 2025. Its market cap has increased by 39.03% in one year.
Market Cap
18.23B
Enterprise Value
15.14B
Revenue
3.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
47.66
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 18.23B, an increase of 132.03%. That is a compound annual growth rate of 10.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 23, 2025 | 18.29B | 14.30% |
Dec 31, 2024 | 16.01B | -18.66% |
Dec 29, 2023 | 19.68B | -7.14% |
Dec 30, 2022 | 21.19B | -41.13% |
Dec 31, 2021 | 35.99B | -29.32% |
Dec 31, 2020 | 50.92B | 85.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 432.92B |
WuXi AppTec | 297.15B |
Shenzhen Mindray Bio-Medical Electronics | 266.31B |
Sichuan Biokin Pharmaceutical | 145.00B |
Shanghai United Imaging Healthcare | 114.80B |
Aier Eye Hospital Group | 113.41B |
Zhangzhou Pientzehuang Pharmaceutical., | 109.44B |
Yunnan Baiyao Group Co.,Ltd | 100.72B |